Severe serum sickness-like syndrome after omalizumab therapy for asthma

Journal of Allergy and Clinical Immunology

Volumn 120, Issue 4, 2007, Pages 972-973

  Pilette, Charles ^a   Coppens, Nathalie ^a   Houssiau, Frédéric A ^a   Rodenstein, Daniel O ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; METHYLPREDNISOLONE; OMALIZUMAB; TELITHROMYCINE; UNCLASSIFIED DRUG;

ACUTE HEART FAILURE; AGED; ALLERGIC ASTHMA; ANTIGEN ANTIBODY COMPLEX; ARTHRALGIA; ASTHMA; CASE REPORT; DRUG WITHDRAWAL; EDEMA; FEMALE; HUMAN; LETTER; MALAISE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PRURITUS; SERUM SICKNESS; SWELLING; TENOSYNOVITIS; ULTRASOUND;

AGED; ANTI-ASTHMATIC AGENTS; ANTIBODIES, MONOCLONAL; ASTHMA; FEMALE; HUMANS; SERUM SICKNESS; SYNDROME;

EID: 34948885158     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.06.038     Document Type: Letter

References (7)

1. Strunk R.C., and Bloomberg G.R. Omalizumab for asthma. N Engl J Med 354 (2006) 2689-2695
2. Dreyfus D.H., and Randolph C.C. Characterization of an anaphylactoid reaction to omalizumab. Ann Allergy Asthma Immunol 96 (2006) 624-627
3. US Food and Drug Administration. Center for Biologics Evaluation and Research. BLA STN 103976/0, briefing document on safety (Genentech Inc) (2003), Department of Health and Human Services, Rockville (MD)
4. Feuring-Buske M., Kneba M., Unterhalt M., Engert A., Gramatzki M., Hiller E., et al. IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in relapsed advanced-stage follicular lymphomas: results of a phase-II study of the German Low-Grade Lymphoma Study Group. Ann Hematol 79 (2000) 493-500
5. Forero A., Shah J., Carlisle R., Triozzi P.L., LoBuglio A.F., Wang W.Q., et al. A phase I study of an anti-GD3 monoclonal antibody, KW-2871, in patients with metastatic melanoma. Cancer Biother Radiopharm 21 (2006) 561-568
6. Graham L.E. Postvaccination serum sickness with de Quervain's tenosynovitis. Rheumatol Int 20 (2001) 251-252
7. Food and Drug Administration (FDA) News. P07-25. Available at http://www.fda.gov/bbs/topics/NEWS/2007/NEW01567.html Accessed June 10, 2007.